Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterodimeric antibodies that bind CD3 and CLDN6

Heterodimeric antibodies that bind CD3 and CLDN6

US Patent 11739144 · Granted Aug 29, 2023

Estimated economic value: $10,744,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion 2025
LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion 2025
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related d2025
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related d2025
Anti-human C5 antibodies2025
Method of manufacturing diester-based compound2025
CTLA4-Ig immunoadhesins2025
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domai2025
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domai2025
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domai2025
Method for preparing synthesis gas2025
Organic compound for capping layer and organic light emitting diode comprising t2025